Literature DB >> 201086

Identification of the target cells in human B lymphocytes for transformation by Epstein-Barr virus.

T Katsuki, Y Hinuma, N Yamamoto, T Abo, K Kumagai.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1977        PMID： 201086     DOI： 10.1016/0042-6822(77)90173-8

Source DB:  PubMed          Journal:  Virology        ISSN： 0042-6822            Impact factor:   3.616


× No keyword cloud information.
  4 in total

Review 1.  Clinical consequences of Epstein-Barr virus infection and possible control by an anti-viral vaccine.

Authors:  M A Epstein; A J Morgan
Journal:  Clin Exp Immunol       Date:  1983-08       Impact factor: 4.330

2.  Frequency of B-lymphocyte transformation by Epstein-Barr virus decreases with entry into the cell cycle.

Authors:  A J Roome; C L Reading
Journal:  Immunology       Date:  1987-02       Impact factor: 7.397

3.  Effective production of anti-tetanus toxoid and anti-HBsAg human monoclonal antibodies by serum-free culture of hybridomas.

Authors:  K Kitano; Y Ichimori; H Sawada; S Iwasa; S Sasai; K Tsukamoto
Journal:  Cytotechnology       Date:  1991-01       Impact factor: 2.058

4.  Interaction of Epstein-Barr virus with leukaemic B cells in vitro. I. Abortive infection and rare cell line establishment from chronic lymphocytic leukaemic cells.

Authors:  A B Rickinson; S Finerty; M A Epstein
Journal:  Clin Exp Immunol       Date:  1982-11       Impact factor: 4.330
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.